4/A: CorMedix COO Amends Ownership Filing for Tax Withholding
Beneficial Ownership Amendment
CorMedix Chief Operating Officer Elizabeth Hurlburt filed an amended Form 4 to correct an omission regarding the withholding of 8,424 common shares for tax liability.
Summary
- Elizabeth Hurlburt, Chief Operating Officer of CorMedix Inc. (CRMD), filed an amended Form 4 (Form 4/A).
- The amendment corrects an omission from a previous Form 4 filed on September 3, 2025.
- The original filing omitted the Issuer's withholding of common stock to satisfy the Reporting Person's tax liability.
- On August 29, 2025, 8,424 shares of common stock were withheld by the Issuer for tax liability.
- The shares were withheld at a price of $14.83 per share.
- Following this transaction, Elizabeth Hurlburt beneficially owns 176,990 shares of CorMedix Inc. common stock.
Sentiment
Score: 5
Explanation: The filing is a neutral, routine compliance update correcting a previous omission. It has no material positive or negative implications for the company or its stock.
Future Outlook
This filing is a historical correction and does not contain any forward-looking statements or guidance regarding the company's future performance or operations.
Industry Context
This is a routine insider transaction filing and amendment, common across all publicly traded companies, and does not reflect broader industry trends or competitive dynamics.
Stakeholder Impact
- Shareholders: Provides updated and accurate information regarding an executive's beneficial ownership, ensuring transparency and compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 08/29/2025 | Date of the transaction where common stock was withheld for tax liability. |
| 09/03/2025 | Date of the original Form 4 filing that omitted the tax withholding details. |
| 09/08/2025 | Date the amended Form 4/A was signed and filed. |
Recommendation
holdThis filing is a routine amendment correcting a previous omission regarding tax withholding for an executive. It does not provide new material information that would alter the investment thesis for CorMedix Inc. and therefore warrants no change in recommendation.
Keywords
CorMedix, CRMD, Form 4/A, Insider Transaction, Beneficial Ownership, Tax Withholding, Elizabeth Hurlburt, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.